作者
Wei Chen, Robert A Mook Jr, Richard T Premont, Jiangbo Wang
发表日期
2018/1/1
来源
Cellular signalling
卷号
41
页码范围
89-96
出版商
Pergamon
简介
Niclosamide is an oral antihelminthic drug used to treat parasitic infections in millions of people worldwide. However recent studies have indicated that niclosamide may have broad clinical applications for the treatment of diseases other than those caused by parasites. These diseases and symptoms may include cancer, bacterial and viral infection, metabolic diseases such as Type II diabetes, NASH and NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-versus-host disease, and systemic sclerosis. Among the underlying mechanisms associated with the drug actions of niclosamide are uncoupling of oxidative phosphorylation, and modulation of Wnt/β-catenin, mTORC1, STAT3, NF-κB and Notch signaling pathways. Here we provide a brief overview of the biological activities of niclosamide, its potential clinical applications, and its challenges for use as a new …
引用总数
20172018201920202021202220232024220306275779350
学术搜索中的文章
W Chen, RA Mook Jr, RT Premont, J Wang - Cellular signalling, 2018